Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver
disease. There has been important progress in the field in recent years and the complexity of …

Over the last two decades, there have been tremendous advances in the non-invasive
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …

Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

Methods: National Health And Nutrition Examination Survey data conducted between 1999
and 2010 were used to estimate cirrhosis prevalence and factors associated with cirrhosis …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

Background & Aims NAFLD is highly prevalent but only a small subset of patients develop
advanced liver fibrosis with impaired liver-related prognosis. We aimed to compare blood …

Nonalcoholic fatty liver disease (NAFLD) ranges from simple hepatic steatosis to non-
alcoholic steatohepatitis (NASH) and cirrhosis. The majority of NAFLD patients do not …

Background. NAFLD ranges from simple steatosis (SS) to non-alcoholic steatohepatitis
(NASH). The natural history of NAFLD and the optimal strategy to identify subjects with …

Liver fibrosis is part of the structural and functional alterations in most chronic liver diseases.
It is one of the main prognostic factors as the amount of fibrosis is correlated with the risk of …